2024. Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s373. DOI:https://doi.org/10.25251/skin.8.supp.373.